国际癌症报告合作组织(ICCR)泌尿道癌活检与经尿道切除标本报告数据集
国际癌症报告合作组织(ICCR)基于文献回顾和专家共识,制定了泌尿道癌活检和经尿道切除标本的病理报告数据集,包含9项必需元素和6项推荐元素,旨在全球范围内标准化数据收集,促进国际协作并减少重复工作。
要点
- 数据集包含9项必需元素和6项推荐元素,用于泌尿道癌活检和经尿道切除标本的报告。
- 必需元素包括标本部位、手术方式、组织学类型、尿路上皮癌亚型、分级、浸润范围、固有肌层状态、非浸润性癌和淋巴血管侵犯。
- 推荐元素包括临床信息、蜡块标识、T1病变范围、相关上皮病变、共存病变和辅助检查。
核心结论
- 该数据集为泌尿道癌活检和经尿道切除标本的病理报告提供了结构化模板,有助于全球范围内协调数据收集,促进国际协作并减少更新国家/机构数据集的重复工作。
研究设计与样本
- 数据集由国际多学科专家小组基于已发表的ICCR癌症数据集指南制定,元素分类基于文献回顾和专家共识。
主要发现
- 数据集包含9项必需元素和6项推荐元素,用于泌尿道癌活检和经尿道切除标本的报告。
关键数值与推荐
- 必需元素包括标本部位、手术方式、组织学肿瘤类型、尿路上皮癌亚型/变异型、肿瘤分级、浸润范围、固有肌层状态、非浸润性癌和淋巴血管侵犯(LVI)。
- 推荐元素包括临床信息、蜡块标识、T1病变范围、相关上皮病变、共存病变和辅助检查。
临床怎么用
- 病理科医生可按照该数据集的结构化模板报告泌尿道癌活检和经尿道切除标本,确保关键要素的完整性和一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The International Collaboration on Cancer Reporting (ICCR) is an alliance of major pathology organisations in Australasia, Canada, Europe, United Kingdom, and United States of America that develops internationally standardised, evidence-based datasets for the pathology reporting of cancer specimens. This dataset was developed by a multidisciplinary panel of international experts based on previously published ICCR guidelines for the production of cancer datasets. It is composed of Required (core) and Recommended (noncore) elements identified on the basis of literature review and expert consensus. The document also includes an explanatory commentary explaining the rationale behind the categorization of individual data items and provides guidance on how these should be collected and reported. The dataset includes nine required and six recommended elements for the reporting of cancers of the urinary tract in biopsy and transurethral resection (TUR) specimens. The required elements include specimen site, operative procedure, histological tumor type, subtype/variant of urothelial carcinoma, tumor grade, extent of invasion, status of muscularis propria, noninvasive carcinoma, and lymphovascular invasion (LVI). The recommended elements include clinical information, block identification key, extent of T1 disease, associated epithelial lesions, coexistent pathology, and ancillary studies. The dataset provides a structured template for globally harmonized collection of pathology data required for management of patients diagnosed with cancer of the urinary tract in biopsy and TUR specimens. It is expected that this will facilitate international collaboration, reduce duplication of effort in updating current national/institutional datasets, and be particularly useful for countries that have not developed their own datasets.
引用
- Varma M, Srigley JR, Brimo F, et al. Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR). Mod Pathol. 2019. PMID: 31685965. doi:10.1038/s41379-019-0403-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。